CISPLATINUM AS A SINGLE AGENT VERSUS CISPLATINUM IN 2 DRUG-COMBINATION IN ADVANCED AND RECURRENT HEAD AND NECK-CANCER

被引：0
|
作者：
CAMPBELL, JB
MORTON, RP
DORMAN, EB
RUGMAN, F
WILSON, JA
STELL, PM
机构：
来源：
CLINICAL OTOLARYNGOLOGY | 1987年 / 12卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
引用
收藏
页码：56 / 56
页数：1
相关论文
共 50 条
  • [1] CONCURRENT CISPLATINUM AND RADIATION FOR ADVANCED HEAD AND NECK-CANCER
    FORASTIERE, AA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (03): : 679 - 680
  • [2] CONCURRENT CISPLATINUM AND RADIATION FOR ADVANCED HEAD AND NECK-CANCER - RESPONSE
    POSNER, MR
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (03): : 681 - 682
  • [3] CONCURRENT CISPLATINUM AND RADIATION WITH OR WITHOUT SURGERY FOR ADVANCED HEAD AND NECK-CANCER
    GLICKSMAN, AS
    SLOTMAN, G
    DOOLITTLE, C
    CLARK, J
    KONESS, J
    COACHMAN, N
    POSNER, M
    DEROSA, E
    WANEBO, H
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 30 (05): : 1043 - 1050
  • [4] CHEMOTHERAPY WITH CISPLATINUM AND BLEOMYCIN AND SUBSEQUENT RADIOTHERAPY IN ADVANCED HEAD AND NECK-CANCER
    SCHMIEDER, A
    JACOBS, H
    MAURER, H
    PFEIFER, H
    KLINISCHE WOCHENSCHRIFT, 1984, 62 (01): : 35 - 42
  • [5] CHEMOTHERAPY IN HEAD AND NECK-CANCER WITH BLEOMYCIN, CISPLATINUM, AND METHOTREXATE
    DEITMER, T
    URBANITZ, D
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1988, 114 (06) : 644 - 646
  • [6] NEOADJUVANT CHEMOTHERAPY WITH CISPLATINUM AND 5-FLUOROURACIL IN ADVANCED HEAD AND NECK-CANCER
    TEATINI, G
    MELONI, F
    BISAIL, M
    MILIA, V
    SANNA, G
    SAROBBA, MG
    MASSIDDA, B
    SCOTTO, T
    FARRIS, A
    JOURNAL OF CHEMOTHERAPY, 1990, 2 (06) : 394 - 396
  • [7] A RANDOMIZED PHASE-III TRIAL OF CISPLATINUM, METHOTREXATE, CISPLATINUM + METHOTREXATE, AND CISPLATINUM + 5-FLUORO-URACIL IN END-STAGE HEAD AND NECK-CANCER
    CAMPBELL, JB
    DORMAN, EB
    MCCORMICK, M
    MILES, J
    MORTON, RP
    RUGMAN, F
    STELL, PM
    STONEY, PJ
    VAUGHAN, ED
    WILSON, JA
    ACTA OTO-LARYNGOLOGICA, 1987, 103 (5-6) : 519 - 528
  • [8] COMBINED MODALITY TREATMENT OF ADVANCED HEAD AND NECK-CANCER USING LOW-DOSE CISPLATINUM AND ACCELERATED FRACTIONATION
    DUHMKE, E
    GEIBEL, T
    GOLMS, R
    KAISER, G
    NOTTER, G
    SCHRODER, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 1988, 164 (01): : 11 - 16
  • [9] TOXICITY OF AGGRESSIVE MULTIMODALITY THERAPY INCLUDING CISPLATINUM, BLEOMYCIN AND METHOTREXATE WITH RADIATION AND OR SURGERY FOR ADVANCED HEAD AND NECK-CANCER
    WEICHSELBAUM, RR
    POSNER, MR
    ERVIN, TJ
    FABIAN, RL
    MILLER, D
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (05): : 909 - 913
  • [10] TRIMETREXATE AS A SINGLE AGENT IN PATIENTS WITH ADVANCED HEAD AND NECK-CANCER
    ROBERT, F
    SEMINARS IN ONCOLOGY, 1988, 15 (02) : 22 - 26
12345